Platelets are storage pools of
growth factors such as platelet-derived growth factor, transforming growth
factor-ß, platelet-derived epidermal growth factor, vascular endothelial growth
factor, insulin-like growth factor-1, fibroblastic growth factor and epidermal
growth factor. Platelets also contain cytokines and other proteins, which
promote wound healing.
Statistics
The global Platelet-Rich
Plasma Market is estimated to account for US$ 352.8 Mn in terms of value in
2020 and is expected to reach US$ 780.8 Mn by the end of 2027.
Global Platelet-rich Plasma
Market: Drivers
Approval and launch of new
products is expected to propel growth of the global platelet-rich plasma market
over the forecast period. For instance, in August 2020, Ortho Regenerative
Technologies Inc. announced that Ortho-R, a Chitosan-based matrix biopolymer
mixed with platelet-rich plasma, is designated as a Drug/Biologic combination
product, by the FDA Office for Combination Products.
Global Platelet-rich Plasma
Market: Opportunities
R&D in platelet-rich plasma
is expected to offer lucrative growth opportunities for players in the global
platelet-rich plasma market. For instance, in September 2020, researchers from
Victoria University, Australia, reported that leucocyte-rich platelet-rich
plasma has a continuous stimulatory anabolic and ergogenic effect on human
fibroblast cells.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/936
Global Platelet-rich Plasma
Market: Restraints
The reimbursement criteria for
the use of platelet-rich plasma therapy in cosmetic surgeries have remained
unchanged, as of April 2014. This fact is likely to restrict the use of
platelet-rich plasma products for cosmetic surgeries. Such scenario is expected
to hinder growth of the global platelet-rich plasma market.
Key Takeaways:
The global platelet-rich plasma
market was valued at US$ 314.6 Mn in 2019 and is forecast to reach a value of
US$ 780.8 Mn by 2027 at a CAGR of 12.0% between 2020 and 2027. Major factor
driving the growth of global platelet rich plasma market during the forecast
period include technological advancement, and increasing prevalence of chronic
diseases.
Pure PRP held dominant position
in the global platelet-rich plasma market in 2019, accounting for 40.9% share
in terms of value, followed by Leukocyte rich PRP and Pure PRF, respectively.
Increasing use of plasma therapy is expected to support growth of the segment
over the forecast period.
Market Trends
Increasing geriatric population
is expected to boost growth of the global platelet-rich plasma market. For
instance, according to the U.S. Census Bureau, the U.S. geriatric population is
expected to reach 77 million by 2034.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/platelet-rich-plasma-market-936
Moreover, increasing adoption of
platelet-rich plasma is also expected to boost growth of the global
Platelet-rich plasma market. For instance, in August 2019, A-to-Zen
Regenerative Medicine in Bellevue, Washington, announced expansion of leading
menu of skin rejuvenation treatments with state-of-the-art platelet-rich plasma
(PRP) Facials and PRP Facelifts for all-natural, age-defying complexion
benefits.
Global Platelet-rich Plasma Market:
Competitive Landscape
Major players operating in the
global platelet-rich plasma market include, Arthrex, Inc., Stryker Corporation,
Johnson and Johnsons Ltd., Zimmer Biomet Holdings Inc., Terumo Corporation,
Glofinn Oy, Medira Ltd., Regen Lab S.A., CollPlant, Generex Biotechnology
Corporation, and Estar Technologies Ltd.
Global Platelet-rich Plasma
Market: Key Developments
Major players in the global
platelet-rich plasma market are focused on adopting M&A strategies to
enhance their market share. For instance, in January 2019, Generex
Biotechnology Corporation entered into a letter of intent to acquire Medisource
Partners, an FDA-registered distributor of medical and surgical products
including supplies kits to process bone marrow aspirates and platelet-rich
plasma biologics at the time of surgery.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/936
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment